MYGN Competitors & Alternatives
Compare Myriad Genetics Inc with similar stocks in the same industry
Diagnostics & Research
MYGN
Main Stock$3.06
Tradestie Score
56
Market Cap
$719.23M
Revenue Growth
-0.2%
Analyst Upside
+88.2%
Top Competitors
38 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VCYT
Veracyte, Inc.
|
$45.49
|
$2.85B | 33.1 | 51 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$69.80
|
$2.24B | - | 51 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$23.23
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$99.11
|
$1.77B | - | 52 | Compare |
|
NEOG
Neogen Corp
|
$11.78
|
$1.26B | - | 58 | Compare |
|
OPK
Opko Health Inc.
|
$1.32
|
$1.23B | - | 53 | Compare |
|
NEO
NeoGenomics, Inc.
|
$15.97
|
$1.13B | - | 48 | Compare |
|
CDNA
CareDx, Inc.
|
$46.75
|
$798.40M | 21.0 | 51 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$30.87
|
$667.77M | - | 57 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$13.33
|
$612.76M | - | 48 | Compare |
More MYGN Analysis
Data updated: Aug 04, 2026 | Industry: Diagnostics & Research (SIC 2835)
38 stocks in this industry